Literature DB >> 6091042

The genetic organization of integrated hepatitis B virus DNA in the human hepatoma cell line PLC/PRF/5.

S Koch, A Freytag von Loringhoven, R Kahmann, P H Hofschneider, R Koshy.   

Abstract

Hepatitis B virus (HBV) DNA is often found integrated in the genome of infected human liver cells and is supposed to be related to the development of primary liver carcinoma (PLC). Four clones of HBV DNA-containing sequences derived from DNA of the human PLC-derived cell line PLC/PRF/5 are discussed. The viral sequences show no intricate rearrangements excepting for a duplication and an inversion in one case, and a deletion in another. In all cases integration of the viral DNA was seen to be in a region which is single-stranded in the unintegrated HBV DNA. Sequence homologies between human and viral DNA flanking the integration sites have been detected. That may have a functional role in integration. Nucleotide sequence analyses of regions encompassing the viral-human junctions reveal open reading frames which consist of viral and/or human information. The possible expression of chimeric or cellular proteins may play a role in tumour development, and offers directions for further investigations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6091042      PMCID: PMC320123          DOI: 10.1093/nar/12.17.6871

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

1.  Evolutionary variants of simian virus 40: Cellular DNA sequences and sequences at recombinant joints of substituted variants.

Authors:  M W Gutai; D Nathans
Journal:  J Mol Biol       Date:  1978-12-05       Impact factor: 5.469

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line.

Authors:  P R Chakraborty; N Ruiz-Opazo; D Shouval; D A Shafritz
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.

Authors:  C Brechot; C Pourcel; A Louise; B Rain; P Tiollais
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

6.  Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.

Authors:  J C Edman; P Gray; P Valenzuela; L B Rall; W J Rutter
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

7.  Isolation, characterization, and comparison of recombinant DNAs derived from genomes of human hepatitis B virus and woodchuck hepatitis virus.

Authors:  I W Cummings; J K Browne; W A Salser; G V Tyler; R L Snyder; J M Smolec; J Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

8.  Construction and characterization of new cloning vehicles. IV. Deletion derivatives of pBR322 and pBR325.

Authors:  X Soberon; L Covarrubias; F Bolivar
Journal:  Gene       Date:  1980-05       Impact factor: 3.688

9.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

10.  Establishment of a continuously growing cell line from primary carcinoma of the liver.

Authors:  J J Alexander; E M Bey; E W Geddes; G Lecatsas
Journal:  S Afr Med J       Date:  1976-12-18
View more
  16 in total

1.  Chromosomal translocation and inverted duplication associated with integrated hepatitis B virus in hepatocellular carcinomas.

Authors:  T Tokino; S Fukushige; T Nakamura; T Nagaya; T Murotsu; K Shiga; N Aoki; K Matsubara
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Subgenomic studies on hepatitis B virus DNA integrated into the genome of hepatocellular carcinoma.

Authors:  K Togawa; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-10

3.  Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children.

Authors:  K Yaginuma; H Kobayashi; M Kobayashi; T Morishima; K Matsuyama; K Koike
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

4.  Integration of hepatitis B virus: analysis of unoccupied sites.

Authors:  I Berger; Y Shaul
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Hepatitis B virus integration in hepatocellular carcinoma DNA: duplication of cellular flanking sequences at the integration site.

Authors:  K Yaginuma; M Kobayashi; E Yoshida; K Koike
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

Review 6.  Hepatitis B virus and hepatocellular carcinoma.

Authors:  P Arbuthnot; M Kew
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

7.  Analysis of integrated ground squirrel hepatitis virus and flanking host DNA in two hepatocellular carcinomas.

Authors:  C Transy; C A Renard; M A Buendia
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues.

Authors:  S Takada; Y Gotoh; S Hayashi; M Yoshida; K Koike
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  Microdeletion associated with the integration process of hepatitis B virus DNA.

Authors:  T Nakamura; T Tokino; T Nagaya; K Matsubara
Journal:  Nucleic Acids Res       Date:  1988-06-10       Impact factor: 16.971

10.  Co-transcribed 3' host sequences augment expression of integrated hepatitis B virus DNA.

Authors:  A F von Loringhoven; S Koch; P H Hofschneider; R Koshy
Journal:  EMBO J       Date:  1985-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.